Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

177
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
177
Pneumonia IV: Management01:28

Pneumonia IV: Management

299
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
299
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

352
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
352
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

232
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
232

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic Strategies for Hepatocellular Carcinoma: Current Advances and Future Perspectives.

Vaccines·2026
Same author

Therapeutic Colorectal Cancer Vaccines: Emerging Modalities and Translational Opportunities.

Vaccines·2025
Same author

<i>In vivo</i> safety evaluation and tracing of arginylglycylaspartic acid-engineered phage nanofiber in murine model.

Journal of materials chemistry. B·2024
Same author

Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective.

Viruses·2023
Same author

Filter-Free, Harmless, and Single-Wavelength Far UV-C Germicidal Light for Reducing Airborne Pathogenic Viral Infection.

Viruses·2023
Same author

Engineered Phage-Based Cancer Vaccines: Current Advances and Future Directions.

Vaccines·2023

Related Experiment Video

Updated: Jun 6, 2025

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.1K

Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies.

Palaniyandi Muthukutty1, Jaime MacDonald1, So Young Yoo1

  • 1Institute of Nanobio Convergence, Pusan National University, Busan 46241, Republic of Korea.

Vaccines
|November 26, 2024
PubMed
Summary

Emerging respiratory viruses like influenza and SARS-CoV-2 cause significant health risks and economic burdens. This review examines current antiviral treatments and discusses future pandemic preparedness strategies, including vaccine and therapy development.

Keywords:
antiviralscoronavirusepidemicinfluenza viruspandemicrespiratory viruses

More Related Videos

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.8K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

15.4K

Related Experiment Videos

Last Updated: Jun 6, 2025

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.1K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.8K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

15.4K

Area of Science:

  • Virology
  • Public Health
  • Infectious Diseases

Background:

  • Emerging viral diseases, including seasonal illnesses and pandemics, represent a major global public health challenge.
  • Respiratory viruses such as coronaviruses and influenza viruses are linked to substantial morbidity, mortality, and socioeconomic impact.
  • Effective management strategies are crucial for mitigating the effects of these viral threats.

Purpose of the Study:

  • To review the current status of respiratory viruses, focusing on influenza and SARS-CoV-2.
  • To examine existing antiviral treatments for these viruses.
  • To discuss future pandemic potential and the development of novel antiviral vaccines and therapies.

Main Methods:

  • Literature review of recent research on respiratory viruses.
  • Analysis of current antiviral drug efficacy and development pipelines.
  • Examination of historical pandemic data and public health responses.

Main Results:

  • Influenza and SARS-CoV-2 remain significant threats requiring ongoing surveillance and treatment.
  • Existing antiviral therapies show varying degrees of effectiveness, necessitating further research.
  • Lessons from past outbreaks highlight the importance of robust pandemic preparedness plans.

Conclusions:

  • Continuous development of broad-spectrum antiviral agents and vaccines is essential.
  • Integrated strategies combining surveillance, treatment, and prevention are key to managing future viral threats.
  • Proactive research and international collaboration are vital for global health security against emerging respiratory viruses.